Hoya Announces Third Quarter and the First Nine Months Financial Results ... ( TOKYO February 5 /- HOYA Corporat...)

Hoya Announces Third Quarter and the First Nine Months Financial Results for FY2008

Date:2/5/2009

TOKYO, February 5 /PRNewswire-FirstCall/ -- HOYA Corporation today announced financial results for the third quarter ended December 31, 2008. Net sales were 112.7 billion yen for the quarter, representing a decrease of 23.3% from 147.0 billion yen in the third quarter of 2007, mainly due to order decrease and the drop in the product price resulting from global economic downturn in the main business fields such as the Electro-Optics and Vision Care, as well as PENTAX that was included in the scope of consolidation during the same period of the previous year.

Operating income for the third quarter fell 39.4%, to 16.6 billion yen, and net income was down 44.2%, to 12.6 billion yen. Earnings per share for the quarter were 29.13 yen compared with 52.22 yen in the third quarter of 2007.

For the first nine months ended December 31, 2008, the company posted a 7.4% increase in net sales over the same period of 2007, to 371.2 billion yen, however, operating income fell 23.2% to 59.1 billion yen, and net income was down 12.8%, to 52.9 billion yen. Earnings per share were 122.31 yen compared with 140.48 yen in the first nine months of 2007.

"Global economic downturn continues to have a negative impact on the Electro-Optics business in this quarter," said Hiroshi Hamada, chief operating officer of HOYA. "However, our medical field is little-affected; especially our endoscopic system business under Pentax brand showed double-digit growth on a local currency bases. We will accelerate structural reforms and at the same time, pursue selective investment and strategic marketing in all fields."

The full quarterly report is available in "Financial Statement" page in HOYA website Investor Relations section at: http://www.hoya.co.jp/english/

*Results are preliminary and unaudited.

*The yen amounts shown therein are
'/>"/>

SOURCE Hoya Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:

(Date:5/23/2013)... May 23, 2013 Graphite Metallizing ... self-lubricating bushings mounted in stainless steel pillow blocks. ... of GRAPHALLOY with the application and installation versatility ... Pillow Blocks work exceptionally well when submerged ... hostile liquids such as acids, alkalies, hydrocarbons, black ...

(Date:5/23/2013)... May 23, 2013 PI’s new ... and provide 15 mm travel range with closed-loop ... small dimensions make these new positioners the ideal ... A vacuum rated version is also available. ... and datasheets can be found at: , ...

(Date:5/23/2013)... On April 19th the Center ... search for the growing antibiotic resistant bacteria that may ... year long study were released late last month showing ... over previous years. For those suffering from bacteria driven ... resistant bacteria in food, may eventually help breed acne ...

(Date:5/23/2013)... 2013 Verenium Corporation (Nasdaq: VRNM ), ... and commercialization of high-performance enzymes, today announced that ... present at two upcoming conferences. (Logo: ... the Second Annual Marcum LLP Microcap Conference on Thursday, ... New York City. The presentation is scheduled to begin ...

Breaking Biology Technology:Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2 Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3 Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2 Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2 Verenium To Present At Two Upcoming Conferences 2 Verenium To Present At Two Upcoming Conferences 3

[0] Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications [0] Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI [0] Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria [0] Verenium To Present At Two Upcoming Conferences

... N.J., July 21 BioNeutral Group, Inc. ("BioNeutral") (OTC ... Science Company announced today that at ATS Labs using ... Antimicrobial passed the difficult Quantitative Disk Carrier test ... difficile (C.diff) present in this test ...

... , , PALO ALTO, Calif., July 21, ... third quarter of its fiscal year 2009 after 1:00 p.m. Pacific Time ... of its investor conference call to review those quarterly results is scheduled ... , That live webcast can be accessed from Varian, ...

... , , KENILWORTH, N.J., July 21 ... for the 2009 second quarter. , , ... given us the strength to again power through tough challenges - delivering ... Fred Hassan, chairman and CEO. , , ...

BioNeutral's Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.Varian, Inc. to Webcast Conference Call on Third Quarter Fiscal Year 2009 Financial Results Schering-Plough Reports Financial Results for 2009 Second Quarter

(Date:5/22/2013)... National Lung Screening Trial (NLST) investigators also conclude ... mortality with low-dose computed tomography (LDCT) versus chest ... primary paper is achievable at experienced screening centers ... more information to share with their patients about ... screening following today,s publication in the New ...

(Date:5/22/2013)... 2013)The omega 3 fatty acids in fish oil have ... so that the American Heart Association currently recommends eating ... fatty varieties rich in omega 3s. However, the mechanism ... a new study, scientists led by Jason R. Carter ... by providing evidence that fish oil might specifically counteract ...

(Date:5/22/2013)... Legionella pneumophila bacteria is responsible for legionellosis, an ... to infect us, this pathogen has developed a complex ... in our cells, thus avoiding these acting against the ... research centre, CIC bioGUNE, in which teams from the ... the National Supercomputation Centre in Barcelona (BSC) have also ...

Breaking Biology News(10 mins):NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2 NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3 Fish oil may help the heart beat mental stress 2 Mechanism discovered which aids Legionella to camouflage itself in the organism 2

[0] NLST: CT detects twice as many lung cancers as X-ray at initial screening exam [1] Fish oil may help the heart beat mental stress [0] Mechanism discovered which aids Legionella to camouflage itself in the organism

... This press release is available in French ... kind, combines two complementary analytical brain imaging techniques, to provide ... the autistic brain. The study, published in the April issue ... by researchers at The Montreal Neurological Institute and Hospital ...

... It,s illegal for health products with medical formulations to be ... on animals ― a situation that has serious ethical and ... by Prof. Amit Gefen of Tel Aviv University,s Faculty of ... be needed for the necessary experimental trials. Dr. Gefen,s ...

... The six sponsoring societies for the meeting ... The American Physiological Society, American Society for Biochemistry ... American Society for Nutrition, and American Society for ... some of the science being presented April 24-28, ...

Cached Biology News:Dual approach gives a more accurate picture of the autistic brain 2 Dual approach gives a more accurate picture of the autistic brain 3 A lab rat -- created in the lab 2 Selected highlights of the research being presented at the Experimental Biology 2010 meeting 2 Selected highlights of the research being presented at the Experimental Biology 2010 meeting 3 Selected highlights of the research being presented at the Experimental Biology 2010 meeting 4

Dual approach gives a more accurate picture of the autistic brain A lab rat -- created in the lab Selected highlights of the research being presented at the Experimental Biology 2010 meeting

This antibody detects cdc42 on SDS-PAGE immunoblots....

Goat polyclonal to Nebraska Calf Diarrhea Virus (FITC) ( Abpromise for all tested applications). Antigen: Bovine (Nebraska Calf Diarrhea Virus)....

DNA fragmentation factor & Inhibitor of CAD...

Rabbit polyclonal to Methionine Aminopeptidase 2 ( Abpromise for all tested applications). entrezGeneID: 10988 SwissProtID: P50579...

Biology Products:

Rabbit Anti-cdc42 / Rac Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents Goat Anti-Human Nebraska Calf Diarrhea Virus Polyclonal Antibody, FITC Conjugated from Abcam Anti-Human DFF45 / ICAD (NT) Polyclonal Antibody, Unconjugated from Cell Sciences Rabbit Anti-Methionine Aminopeptidase 2 Polyclonal Antibody, Unconjugated from Abcam